05:12 AM EDT, 08/14/2024 (MT Newswires) -- AnaptysBio ( ANAB ) said Wednesday it priced its underwritten offering of about 2.8 million common shares at $36.50 per share for expected gross proceeds of about $100 million.
Net proceeds from the offering, which is set to close about Thursday, will be used primarily for general corporate purposes.